Coordonnées

Expérience professionelle

Domaine d'activité : santé
Type de contrat : CDD
Fonction exercée : biostatisticiens
Organisme de rattachement ou entreprise : unité de recherche EA3279
Ville : marseille
Pays : FRANCE

Adresse professionnelle

Laboratoire de Santé Publique - 1er étage - Aile Rouge Faculté de Médecine de Marseille. 27, bd Jean Moulin 13005 MARSEILLE

Doctorat

Intitulé : Biologie-Santé - Spécialité Recherche Clinique et Santé Publique
1ère inscription en thèse : Décembre 2011
École doctorale : Sciences de la Vie et de la Santé
Date de soutenance de la thèse : 16 Décembre 2015
Sujet : Caractérisation de l’effet "response shift" par l’approche des forêts aléatoires Application à la sclérose en plaques et à la schizophrénie
Directeur de thèse : Pascal AUQUIER
Co-directeur : Badih GHATTAS
Unité de recherche : SPMC - Santé Publique et Maladies Chroniques : Qualité de Vie, Concepts, Usages et Limites, Déterminants
Intitulé de l'équipe :

Master

Intitulé : Mathématiques et Applications
Septembre 2011 - U1
Mention : assez bien

Langues vivantes

:
:

Production scientifique

  • Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
    BMC Med Res Methodol. 2013
    Boucekine M, Loundou A, Baumstarck K, Minaya-Flores P, Pelletier J, Ghattas B, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/23414459
  • Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.
    Health Qual Life Outcomes 2013
    Baumstarck K, Butzkueven H, Fernández O, Flachenecker P, Stecchi S, Idiman E, Pelletier J, Boucekine M, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/23895207
  • Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia.
    Psychiatry Res. 2013
    Boyer L, Richieri R, Dassa D, Boucekine M, Fernandez J, Vaillant F, Padovani R, Auquier P, Lancon C.
    http://www.ncbi.nlm.nih.gov/pubmed/23850204
  • Measuring quality of life in patients with schizophrenia:an overview.
    Expert Rev Pharmacoecon Outcomes Res 2013
    Boyer L, Baumstarck K, Boucekine M, Blanc J, Lançon C, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/23763531
  • What is the relevance of quality of life assessment for patients with attention impairment?
    Health Qual Life Outcomes 2013
    Baumstarck K, Boucekine M, Klemina I, Reuter F, Aghababian V, Loundou A, Pelletier J, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/23618058
  • Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment.
    Schizophr Res. 2013
    Baumstarck K, Boyer L, Boucekine M, Aghababian V, Parola N, Lançon C, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/23566495
  • Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
    J Thromb Haemost. 2013
    Lacroix R, Judicone C, Mooberry M, Boucekine M, Key NS, Dignat-George F
    http://www.ncbi.nlm.nih.gov/pubmed/23551930
  • Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge
    Mult Scler Int. 2013
    Baumstarck K, Boyer L, Boucekine M, Michel P, Pelletier J, Auquier P
    http://www.ncbi.nlm.nih.gov/pubmed/23533758
  • Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis
    Eur J Neurol. 2013
    Baumstarck K, Pelletier J, Butzkueven H, Fernández O, Flachenecker P, Idiman E, Stecchi S, Boucekine M, Auquier P
    http://www.ncbi.nlm.nih.gov/pubmed/23347258
  • Relevance of quality of life assessment for multiple sclerosis patients with memory impairment
    PLoS One. 2012
    Baumstarck K, Reuter F, Boucekine M, Aghababian V, Klemina I, Loundou A, Pelletier J, Auquier P
    http://www.ncbi.nlm.nih.gov/pubmed/23239975
  • Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach
    PLoS One. 2012
    Boyer L, Cermolacce M, Dassa D, Fernandez J, Boucekine M, Richieri R, Vaillant F, Dumas R, Auquier P, Lancon C
    http://www.ncbi.nlm.nih.gov/pubmed/23144705
  • Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center
    Intensive Care Med 2013
    Roch A, Hraiech S, Masson E, Grisoli D, Forel JM, Boucekine M, Morera P, Guervilly C, Adda M, Dizier S, Toesca R, Collart F, Papazian L
    http://www.ncbi.nlm.nih.gov/pubmed/24170143
  • Statistical challenges of quality of life and cancer: new avenues for future research
    Expert Rev Pharmacoecon Outcomes Res 2014
    Laurent Boyer Karine Baumstarck Pierre Michel Mohamed Boucekine Amelie Anota Franck Bonnetain Joel Coste Bruno Falissard Alice Guilleux Jean-Benoit Hardouin Anderson Loundou Mariette Mercier Mounir Mesbah Alexandra Rouquette Veronique Sebille Mathilde GE Verdam Badih Ghattas Francis Guillemin Pascal Auquier
    http://www.ncbi.nlm.nih.gov/pubmed/24378121
  • Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.
    BMC Neurol 2014
    Baumstarck K1, Boucekine M, Boyer L, Aghababian V, Parola N, Reuter F, Loundou A, Lançon C, Pelletier J, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/24708665
  • Spanish cross-cultural adaptation and psychometric properties of the Schizophrenia Quality of Life short-version questionnaire (SQoL18) in 3 middle-income countries: Bolivia, Chile and Peru.
    Schizophr Res 2014
    Caqueo-Urízar , Boyer L, Boucekine M, Auquier P.
    http://www.ncbi.nlm.nih.gov/pubmed/25212841
  • Exploring the response shift effect on the quality of life of patients with schizophrenia: an application of the Random Forest method
    Medical Decision Making 2014
    Mohamed Boucekine, Laurent Boyer, Karine Baumstarck1, Aurelie Millier, Badih Ghattas, Pascal Auquier, Mondher Toumi
    http://mdm.sagepub.com/content/early/2014/11/14/0272989X14559273
  • 18 FDG-PET in different subtypes of temporal lobe epilepsy: SEEG validation and predictive value.
    Epilepsia. 2015
    Guedj E, Bonini F, Gavaret M, Trébuchon A, Aubert S, Boucekine M, Boyer L, Carron R, McGonigal A, Bartolomei F.
    http://www.ncbi.nlm.nih.gov/pubmed/25708545
  • Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Revue Neurologique 2015
    Baumstarck K, Pelletier J, Boucekine M, Auquier P; MusiQoL study group.
    http://www.ncbi.nlm.nih.gov/pubmed/25558798
  • The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey.
    Journal of Affective Disorders 2015
    Fond G, Zendjidjian X, Boucekine M, Brunel L, Llorca PM, Boyer L.
    http://www.ncbi.nlm.nih.gov/pubmed/26368948